April 30, 2025
TOPLINE: Medical and nonmedical use of prescription drugs, as well as peer-to-peer diversion, decreased significantly among adolescents in the United States between 2009 and 2022, a […]
April 29, 2025
People of all ages now grow up — and grow old — immersed in digital screens, generating concerns about the potential effects on the brain. On […]
April 29, 2025
The 33rd European Congress of Psychiatry, held recently in Madrid, Spain, focused on mental health care and prevention strategies for healthcare professionals at different stages of […]
April 25, 2025
MADRID — Recent research on the progression and treatment of psychosis is prompting some experts to ask: Are substance-induced psychosis (SIP) and primary psychosis fundamentally different? […]
April 25, 2025
TOPLINE: Depression and loneliness predicted memory decline over time in older adults, while memory decline worsened mood symptoms, according to a new study that highlighted a […]
April 25, 2025
Adjunctive use of xanomeline/trospium chloride (Cobenfy) offered no statistically significant benefit over placebo in adults with symptoms of schizophrenia inadequately controlled by an atypical antipsychotic, according […]
April 24, 2025
Since 2019, the number of people in the United States using psilocybin has gone up sharply, which lines up with when some states began to decriminalize […]
April 23, 2025
MADRID — Virtual reality (VR)–based cognitive behavioral therapy (CBT) may be an alternative treatment option for patients with paranoia based on results of a new randomized, […]
April 23, 2025
Adequate treatment of high blood pressure (BP) can substantially lower the risk for dementia or cognitive impairment without dementia, new data indicated. In a large study […]